Observational studyBMJ open ophthalmology2026

Systemic α₂-agonist use and lower hazard of glaucoma compared with β-blockers: a cohort study.

Ibrahim Abboud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.